Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Return on Sales: 2022-2025

Historic Return on Sales for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to 0.29%.

  • MDxHealth's Return on Sales rose 16.00% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.30%, marking a year-over-year increase of 19.00%. This contributed to the annual value of 0.42% for FY2024, which is 19.00% up from last year.
  • MDxHealth's Return on Sales amounted to 0.29% in Q3 2025, which was down 5.53% from 0.28% recorded in Q2 2025.
  • MDxHealth's 5-year Return on Sales high stood at 0.27% for Q4 2024, and its period low was 1,391.50% during Q2 2022.
  • Over the past 3 years, MDxHealth's median Return on Sales value was 0.45% (recorded in 2024), while the average stood at 0.46%.
  • Per our database at Business Quant, MDxHealth's Return on Sales crashed by 15,219bps in 2022 and then skyrocketed by 139,086bps in 2023.
  • MDxHealth's Return on Sales (MRQ) stood at 133.75% in 2021, then soared by 99bps to 0.95% in 2022, then skyrocketed by 42bps to 0.55% in 2023, then surged by 51bps to 0.27% in 2024, then dropped by 7bps to 0.29% in 2025.
  • Its Return on Sales was 0.29% in Q3 2025, compared to 0.28% in Q2 2025 and 0.37% in Q1 2025.